Analysts have revised their earnings per share (EPS) estimates for several companies as of January 21, reflecting changing market conditions and company performance. These updates cover a range of sectors, from real estate to biotechnology, providing investors with crucial insights into potential stock movements.
Key Changes in Analyst Ratings
ABM Industries (NYSE:ABM) received a hold rating from analysts at Truist Financial Corporation, with a target price adjusted to $47.00, down from $58.00. This change indicates a more cautious outlook on the company’s future performance.
In the biotechnology sector, Aclaris Therapeutics (NASDAQ:ACRS) maintained a buy rating from analysts at HC Wainwright, who set a target price of $16.00. This suggests continued confidence in the company’s growth potential.
American Homes 4 Rent (NYSE:AMH) also saw its market outperform rating reaffirmed by Citizens Jmp, which established a target price of $41.00. This reflects a positive outlook for the real estate investment trust amid ongoing market fluctuations.
Additional Noteworthy Adjustments
Several other companies experienced significant adjustments in their ratings. APA (NASDAQ:APA) was reaffirmed with an underweight rating by Barclays PLC, suggesting that analysts foresee challenges ahead for the company. Similarly, Casey’s General Stores (NASDAQ:CASY) was downgraded from a buy to a neutral rating by Northcoast Research, indicating a more tempered view on its growth trajectory.
Citizens Jmp initiated coverage on Century Communities (NYSE:CCS), issuing a market outperform rating and a target price of $92.00. This reflects a growing optimism in the housing sector, which is gaining traction amid rising demand.
Cogent Biosciences (NASDAQ:COGT) had its outperform rating reaffirmed by analysts at Wedbush, who maintain a target price of $55.00. This recommendation highlights sustained confidence in the company’s pipeline and market strategy.
As analysts continue to scrutinize various sectors, these updated ratings and price targets serve as important indicators for investors navigating the complex landscape of financial markets.
